The ECFS Non Tuberculous Mycobacteria (NTM) Working Group has three main aims:
a. Develop NTM management guidelines
b. Develop NTM-specific fields for the ECFS Patient Registry
c. Facilitate in the development of a greater evidence base for the management of NTM infection in CF
21 January 2016
The ECFS is happy to announce the publication of the US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.
The recommendations are published as a supplement to Thorax, Thorax 2016 Jan; 71(Suppl 1): 1-22.
At the 2013 ECFS Conference in Lisbon, on Friday 14 June, the following Special Symposium was held:
Special Symposium - ECFS/CFF Guidelines for the Management of Non Tuberculous Mycobacteria in CF
Moderators: C. Haworth (UK) / B. Marshall (US)
The microbiology of nontuberculous mycobacteria - Jean Louis Herrmann (FR)
Epidemiology and risk factors for NTM – Andres Floto (UK)
Diagnosing NTM in CF – Charles Haworth (UK)
Treatment of Mycobacterium – Ken Olivier (US)